Skip to content
![3D In-Vitro Fibroblast-Patient Derived Organoid Co-Culture: A High-Throughput Platform for Inflammatory Bowel Disease Drug Development]()
October 24, 2024
3D In-Vitro Fibroblast-Patient Derived Organoid Co-Culture: A High-Throughput Platform for Inflammatory Bowel Disease Drug Development
read more
![Reconstructing tumor microenvironment with patient-derived organoids for derisking Immuno-Oncology therapies]()
October 24, 2024
Reconstructing tumor microenvironment with patient-derived organoids for derisking Immuno-Oncology therapies
read more
![Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity]()
April 29, 2024
Patient-derived organoids as a reliable screening platform for assessing ADC efficacy and specificity
read more
![Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets]()
April 29, 2024
Resistant PDO models: Unraveling drug resistance mechanisms for discovering new drug targets
read more
![Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy]()
April 29, 2024
Patient-derived organoids: A pre-clinical model to assess infection and killing capacity of viral vectors for cancer therapy
read more
![Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy]()
April 29, 2024
Tumor organoid and immune cells co-cultures to study myeloid cells-targeting immunotherapy
read more
![Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model]()
April 29, 2024
Mechanistic validation of MAIT cell engagers in HUB Patient-Derived Organoids (PDO) co-culture model
read more
![A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors]()
April 29, 2024
A patient-derived organoid platform to assess the effectiveness of γδTCR cell therapy in solid tumors
read more
